HMGB2 stabilizes p53 by interfering with E6/E6AP-mediated p53 degradation in human papillomavirus-positive HeLa cells

Cancer Letters

Volumn 292, Issue 1, 2010, Pages 125-132

  Lee, Daekyun ^a   Kwon, Jung Hee ^a   Kim, Eui Ho ^b   Kim, Eung Sam ^a   Choi, Kwan Yong ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

HeLa cells; High mobility group B2; HPV E6; P53 degradation

Indexed keywords

ACTININ; HIGH MOBILITY GROUP B2 PROTEIN; PROTEIN E6; PROTEIN P21; PROTEIN P53; SMALL INTERFERING RNA; DNA BINDING PROTEIN; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN MCF 7; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; UBIQUITINATION; WART VIRUS; CELL CYCLE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; TUMOR CELL LINE; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; HELA CELLS; HMGB2 PROTEIN; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN STABILITY; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITINATION;

EID: 77951212834     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.11.015     Document Type: Article

References (19)

1. Bianchi M.E., Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr. Opin. Genet. Dev. 2005, 15:496-506.
2. Thomas J.O., Travers A.A. HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem. Sci. 2001, 26:167-174.
3. Fan Z., Beresford P.J., Zhang D., Lieberman J. HMG2 interacts with the nucleosome assembly protein set and is a target of the cytotoxic T-lymphocyte protease granzyme A. Mol. Cell. Biol. 2002, 22:2810-2820.
4. Yumoto Y., Shirakawa H., Yoshida M., Suwa A., Watanabe F., Teraoka H. High mobility group proteins 1 and 2 can function as DNA-binding regulatory components for DNA-dependent protein kinase in vitro. J. Biochem. 1998, 124:519-527.
5. Aidinis V., Bonaldi T., Beltrame M., Santagata S., Bianchi M.E., Spanopoulou E. The RAG1 homeodomain recruits HMG1 and HMG2 to facilitate recombination signal sequence binding and to enhance the intrinsic DNA-bending activity of RAG1-RAG2. Mol. Cell. Biol. 1999, 19:6532-6542.
6. Dubois T., Howell S., Zemlickova E., Aitken A. Identification of casein kinase Iα interacting protein partners. FEBS Lett. 2002, 517:167-171.
7. Butteroni C., De Felici M., Schöler H.R., Pesce M. Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins. J. Mol. Biol. 2000, 304:529-540.
8. Stros M., Ozaki T., Bacikova A., Kageyama H., Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J. Biol. Chem. 2002, 277:7157-7164.
9. Vousden K.H., Lane D.P. p53 in health and disease. Nat. Rev. Mol. Cell. Biol. 2007, 8:275-283.
10. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
11. Lukashchuk N., Vousden K.H. Ubiquitination and degradation of mutant p53. Mol. Cell. Biol. 2007, 27:8284-8295.
12. Jayaraman L., Moorthy N.C., Murthy K.G., Manley J.L., Bustin M., Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev. 1998, 12:462-472.
13. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
14. Hengstermann A., Linares L.K., Ciechanover A., Whitaker N.J., Scheffner M. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. Proc. Natl. Acad. Sci. USA 2001, 98:1218-1223.
15. Imamura T., Izumi H., Nagatani G., Ise T., Nomoto M., Iwamoto Y., Kohno K. Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein. J. Biol. Chem. 2001, 276:7534-7540.
16. Hall A.H.S., Alexander K.A. RNA interference of human papillomavirus type 18 e6 and e7 induces senescence in HeLa Cells. J. Virol. 2003, 77:6066-6069.
17. * protein inhibits E6-mediated degradation of p53 and suppressed transformed cell growth. Oncogene 1997, 15:257-264.
18. Wei Q. Pitx2a binds to human papillomavirus type 18 E6 protein and inhibits E6-mediated P53 degradation in HeLa cells. J. Biol. Chem. 2005, 280:37790-37797.
19. Howie H.L., Katzenellenbogen R.A., Galloway D.A. Papillomavirus E6 proteins. Virology 2009, 384:324-334.